VNDA

VNDA

Vanda Pharmaceuticals Inc. Common Stock

$4.590+-0.000 (-0.000%)

Prix en Temps Réel

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$4.590

Haut

$4.590

Bas

$4.590

Volume

0.18M

Fondamentaux de l'Entreprise

Statistiques de Trading

Actualités Connexes

PR Newswire

Vanda Pharmaceuticals Announces Presentation at 2025 ASCP Annual Meeting

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced participation at the American Society of Clinical Psychopharmacology (ASCP) Annual...

Voir plus
Vanda Pharmaceuticals Announces Presentation at 2025 ASCP Annual Meeting
PR Newswire

Vanda Pharmaceuticals Announces Participation in the Mizuho Neuro & Ophthalmology Summit 2025

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in investor meetings at the Mizuho Neuro &...

Voir plus
Vanda Pharmaceuticals Announces Participation in the Mizuho Neuro & Ophthalmology Summit 2025
Analyst Upgrades

Cantor Fitzgerald Assumes Vanda Pharmaceuticals at Overweight, Announces Price Target of $13

Cantor Fitzgerald analyst Olivia Brayer assumes Vanda Pharmaceuticals with a Overweight rating and announces Price Target of $13.

Voir plus
Cantor Fitzgerald Assumes Vanda Pharmaceuticals at Overweight, Announces Price Target of $13
PR Newswire

Vanda Pharmaceuticals Reports First Quarter 2025 Financial Results

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced financial and operational results for the first quarter ended March 31, 2025....

Voir plus
Vanda Pharmaceuticals Reports First Quarter 2025 Financial Results